0.0035
0.0000
(0.00%)
May 22 - Close
OTCMKTS
data delayed by 15 mins -
Disclaimer
Currency in USD
| Range | - |
| 52 week | 0.00 - 0.10 |
| Open | - |
| Vol / Avg. | 0.00/12,175.00 |
| Mkt cap | 304,615.00 |
| P/E | - |
| Div/yield | - |
| EPS | -0.06 |
| Shares | 87.03M |
| Beta | 1.73 |
| Inst. own | 40% |
Key stats and ratios
| Q2 (Jun '12) | 2011 | |
| Net profit margin | -79.55% | -180.34% |
| Operating margin | -174.70% | -187.24% |
| EBITD margin | - | -186.94% |
| Return on average assets | -85.53% | -121.77% |
| Return on average equity | - | - |
| Employees | 10 | - |
| Carbon Disclosure Rating | - | - |
Address
Building 200, One Kendall Square
CAMBRIDGE, MA 02139
United States - Map
+1-617-2641800 (Phone)
+1-302-6555049 (Fax)
CAMBRIDGE, MA 02139
United States - Map
+1-617-2641800 (Phone)
+1-302-6555049 (Fax)
Website links
External links
Discussion Group - Google Finance
Advertisement
Description
Helicos Biosciences Corporation is a United States-based life science company. The Company develops genetic technologies for the research, drug discovery and clinical diagnostics markets. The Company's True Single Molecule Sequencing (tSMS(TM)) technology allows the direct measurement of natural DNA without the confounding steps of sample manipulation or nucleic acid amplification. It offers a Helicos Genetic Analysis System, is comprised of the HeliScope Sequencer, HeliScope Sequencer Operation, HeliScope Analysis Engine, HeliScope Sample Loader, and HeliScope Control Center
Officers and directors
| Jeffrey R. Moore | Chief Financial Officer, Senior Vice President | |
| Bruce C. Ginsberg | Director | |
| Ronald A. Lowy | Director |